U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202331

Expand all

EDARBYCLOR (AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE)
EQ 40MG MEDOXOMIL;12.5MG
Marketing Status: Prescription
Active Ingredient: AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
Proprietary Name: EDARBYCLOR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 40MG MEDOXOMIL;12.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N202331
Product Number: 001
Approval Date: Dec 20, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
EDARBYCLOR (AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE)
EQ 40MG MEDOXOMIL;25MG
Marketing Status: Prescription
Active Ingredient: AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
Proprietary Name: EDARBYCLOR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 40MG MEDOXOMIL;25MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N202331
Product Number: 002
Approval Date: Dec 20, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top